RARRES2 and adrenal cortex carcinoma: The mechanism of reduced chemerin expression in adrenocortical carcinoma appears to be through repressive hypermethylation at 5 CpG sites, which could be reversed by the DNA-methyltransferase inhibitor decitabine [79].